Showing results (1301-1310 of 2,331) with videos related to

Sort By:
Pageof 234
Clinical Drug Investigation|August 12, 2018
A Network Pharmacology-Based Analysis of Multi-Target, Multi-Pathway, Multi-Compound Treatment for Ovarian Serous CystadenocarcinomaDan-Dan Xiong, Yue Qin, Wen-Qing Xu, et al.
Clinical Drug Investigation|May 2, 2018
Health Economic Analysis of Antiplatelet Therapy for Acute Coronary Syndromes in the Context of Five Eastern Asian CountriesBin Wu, Ruoyan Gai Tobe, Yuchen Liu, et al.
Clinical Drug Investigation|April 6, 2018
Translating Benzodiazepine Utilization Data into Meaningful Population Exposure: Integration of Two Metrics for Improved ReportingJaden Brandt, Wajd Alkabanni, Silvia Alessi-Severini, et al.
Clinical Drug Investigation|September 3, 2016
Value of Sustained Virologic Response in Patients with Hepatitis C as a Function of Time to Progression of End-Stage Liver DiseaseThomas Ward, Jason Gordon, Beverley Jones, et al.
Clinical Drug Investigation|March 16, 2010
Six-month evaluation of the benefits of the low-dose combined oral contraceptive chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg in young women: results of the prospective, observational, non-interventional, multicentre TeeNIS studySabine Anthuber, Georg A K Schramm, Marie-Luise S Heskamp
Clinical Drug Investigation|March 16, 2010
Long-term chelation therapy with deferasirox: effects on cardiac iron overload measured by T2* MRIGiovan Battista Ruffo, Zelia Borsellino, Liana Cuccia, et al.
Clinical Drug Investigation|June 9, 2018
Paliperidone Palmitate 3-Monthly Versus 1-Monthly Injectable in Patients With Schizophrenia With or Without Prior Exposure to Oral Risperidone or Paliperidone: A Post Hoc, Subgroup AnalysisMaju Mathews, Huiling Pei, Adam Savitz, et al.
Clinical Drug Investigation|October 14, 2018
Physicians' and Pharmacists' Clinical Considerations for Elderly Patients with Type 2 Diabetes Mellitus: The IMPLICA2 StudyJosep Franch-Nadal, Fermín García-Gollarte, Alfonso Pérez Del Molino, et al.
Clinical Drug Investigation|June 7, 2019
Inflammatory Bowel Disease Onset During Secukinumab Treatment: Real Concern or Just an Expression of Dysregulated Immune Response?Walter Fries, Alessandra Belvedere, Maria Cappello, et al.
Clinical Drug Investigation|September 8, 2018
Safety of Edoxaban 30 mg in Elderly Patients with Severe Renal ImpairmentGiovanni Fazio, Ilaria Dentamaro, Rosanna Gambacurta, et al.
Pageof 234